Adi Mashiach

Adi is a repeat founder of AI-driven biotech startups, former physician, and computational systems biology researcher. He was the founder of Nyxoah (NASDAQ:NYXH), a leading sleep apnea therapy based on a neurotech and adaptive learning platform. He founded Innovea (acquired), a medical imaging startup focused on diffusion-based computer vision. His innovative research in machine learning and nonlinear dynamics predicted cancer therapy responses from cell images. Adi holds over 85 US patents.